- Home
- ATOM vs MIST Comparison
ATOM vs MIST Comparison
Compare ATOM & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOM
- MIST
- Stock Information
- Founded
- ATOM 2001
- MIST 2003
- Country
- ATOM United States
- MIST Canada
- Employees
- ATOM N/A
- MIST N/A
- Industry
- ATOM Semiconductors
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- ATOM Technology
- MIST Health Care
- Exchange
- ATOM Nasdaq
- MIST Nasdaq
- Market Cap
- ATOM 100.9M
- MIST 81.5M
- IPO Year
- ATOM 2016
- MIST N/A
- Fundamental
- Price
- ATOM $5.79
- MIST $1.70
- Analyst Decision
- ATOM Strong Buy
- MIST Strong Buy
- Analyst Count
- ATOM 1
- MIST 3
- Target Price
- ATOM $7.00
- MIST $13.00
- AVG Volume (30 Days)
- ATOM 461.9K
- MIST 524.5K
- Earning Date
- ATOM 10-29-2024
- MIST 11-12-2024
- Dividend Yield
- ATOM N/A
- MIST N/A
- EPS Growth
- ATOM N/A
- MIST N/A
- EPS
- ATOM N/A
- MIST N/A
- Revenue
- ATOM $662,000.00
- MIST N/A
- Revenue This Year
- ATOM N/A
- MIST N/A
- Revenue Next Year
- ATOM $2,800.00
- MIST N/A
- P/E Ratio
- ATOM N/A
- MIST N/A
- Revenue Growth
- ATOM 13140.00
- MIST N/A
- 52 Week Low
- ATOM $2.31
- MIST $1.12
- 52 Week High
- ATOM $9.19
- MIST $3.52
- Technical
- Relative Strength Index (RSI)
- ATOM 69.99
- MIST 54.46
- Support Level
- ATOM $4.30
- MIST $1.66
- Resistance Level
- ATOM $7.11
- MIST $1.88
- Average True Range (ATR)
- ATOM 0.61
- MIST 0.16
- MACD
- ATOM 0.14
- MIST 0.02
- Stochastic Oscillator
- ATOM 65.17
- MIST 42.86
About ATOM Atomera Incorporated
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the most widely used transistor type in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, FinFET technology, logic and processors, and SRAM.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).